Today's Short Setups
Names where bearish research, officer net selling, analyst downgrades, and price weakness are stacking. The profile of a stock that's deteriorating, not one to fade impulsively. Squeeze hazard is penalized; crowded shorts get filtered out. Research only, not advice.
- 01RGCspeculative biotech unwindRegencell Bioscience Holdings LtdA 282% implied downside-to-target is the dominant signal here — an extreme valuation dislocation for a micro-cap bioscience name already down 23% in 20 days, pointing to severe fundamental overvaluation; low short float (~1.4%) limits squeeze risk.62$2.83B
- 02MIMImicro-cap post-hype unwindMint Inc LtdMIMI has collapsed 35.6% in 20 days with a 30% additional downside target and a bearish rating, suggesting a small-cap momentum unwind with no insider or analyst signals to complicate the thesis; short float of ~4% keeps squeeze risk low.62$14.69M
- 03OIOmicro-cap post-hype unwindOIO GroupOIO carries a 60.8% downside-to-target with a bearish rating and negligible short float (0.07%), suggesting an illiquid micro-cap with little institutional support and meaningful valuation air beneath it, though near-flat 20-day price action is a weak momentum signal.56$699.52M
- 04FTRKmicro-cap post-hype unwindFast Track GroupFast Track Group shows a 32.4% downside-to-target and a bearish rating, but the slightly positive 20-day return (+1.4%) and absence of insider or analyst signals make this a low-conviction setup driven almost entirely by valuation gap; negligible short float means no squeeze risk.52$10.11M
- 05OPENLOpendoor Technologies Inc.OPENL appears to be a warrant or preferred instrument tied to Opendoor Technologies rather than the common equity (OPEN), and the negative target_downside_pct (-38.8%) implies the instrument is already trading below any analyst target, making the signal unreliable for a clean short thesis.50·
- 06VRXAVeraxa Biotech Holding AGVeraxa Biotech shows a negative downside-to-target (-18.4%), meaning the stock is already below consensus target, and with no insider, analyst, or short-interest signals available, there is insufficient stacking of bearish evidence to surface a credible short idea.49$259.48M
- 07SDOTmicro-cap mean-reversion / fraud concernSadot Group Inc.Sadot Group's 124.9% downside-to-target is the dominant signal, but the stock has surged +191% in 20 days — a violent short-squeeze or pump dynamic — and with ~9.9% short float this is a high-risk, potentially dangerous short despite the extreme valuation gap; do NOT ignore squeeze risk here.37$19.01M
- 08TCBKTRICO BANCSHARES /Trico Bancshares is a well-established community bank with a near-zero downside-to-target (-1.2%), a neutral rating, and positive 20-day price action (+10.7%); the two analyst downgrades are the only bearish signal and are insufficient to build a short thesis on a large, liquid regional bank.31$1.91B
Get both lists every morning
Tomorrow's longs + today's shorts in your inbox daily. Free, no account needed.
Free daily email · unsubscribe anytime · no account needed.
Shorting is asymmetric.
A long can go to zero; a short can go to infinity. Names with high short interest carry squeeze risk that can erase a year of returns in a session. Even a thesis grounded in real deterioration can be wrong on timing. Treat these as research candidates, not recommendations.
Run an AI long/short book
Sign up free to deploy these short setups inside a market-neutral or long/short strategy on Hyperliquid. Tomorrow Terminal handles the sizing, risk caps, and intraday watcher; you bring the steer.